The sell-side on Wall Steet is predicting Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) to grow at an accelerated rate over the next five years. Sell-side analysts are looking for the company to grow -2.30% over the next year and 46.09% over the next five years.
EPS measures what each share is worth and also indicates how much money their sharehoders would gain if the company was to pay out all of its profits. Earnings Per Share is computed by dividing the total profit by its total shares. Alnylam Pharmaceuticals, Inc.’s trailing 12- months EPS is -5.25. Last year, their EPS growth was -38.70% and their EPS growth over the past five years was -28.70%.
Let’s start off by taking a look at how the stock has been performing recently. Over the past twelve months, Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)’s stock was 244.85%. Last week, it was -1.07%, 60.64% over the last quarter, and 79.29% for the past half-year.
Over the past 50 days, Alnylam Pharmaceuticals, Inc. stock was -13.04% off of the high and 81.43% removed from the low. Their 52-Week High and Low are noted here. -13.04% (High), 256.81%, (Low).
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)’s performance this year to date is 244.85%. The stock has performed -1.07% over the last seven days, 4.97% over the last thirty, and 60.64% over the last three months. Over the last six months, Alnylam Pharmaceuticals, Inc.’s stock has been 79.29% and 177.42% for the year.
FUTURE GROWTH ESTIMATES AND RECOMMENDATIONS
Wall Street analysts are have a consensus analyst recommendation of 2.20 on the stock. This is based on a 1-5 scale where 1 represents a Strong Buy and 5 a Strong Sell. Brokerages covering the name have a $143.17 on the stock.
The advice provided on this website is general advice only. It has been prepared without taking into account your objectives, financial situation or needs. Before acting on this advice you should consider the appropriateness of the advice, having regard to your own objectives, financial situation and needs. Where quoted, past performance is not indicative of future performance.